JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor α and βc subunit, respectively, and are activated upon IL-5 stimulation

Blood

Volumn 91, Issue 7, 1998, Pages 2264-2271

  Ogata, Norihisa ^b   Kouro, Taku ^b   Yamada, Atsuko ^b   Koike, Masamichi ^b   Hanai, Nobuo ^b   Ishikawa, Takeru ^b   Takatsu, Kiyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE;

ARTICLE; DIMERIZATION; ENZYME BINDING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION;

EID: 0032055856     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.7.2264     Document Type: Article

References (43)

1. Takatsu K: Interleukin-5. Curr Opin Immunol 4:299, 1992
2. Takatsu K, Takaki S, Hitoshi Y: Interleukin-5 and its receptor system: Implications in the immune system and inflammation. Adv Immunol 57:145, 1994
3. Sanderson CJ: Interleukin-5, eosinophils, and disease. Blood 79:3101, 1992
4. Miyajima A: Molecular structure of the IL-3, GM-CSF and IL-5 receptors. Int J Cell Cloning 10:126, 1992
5. Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K: Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med 175:341, 1992
6. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G: A human high affinity interleukin-5 receptor (IL5) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 66:1175, 1991
7. Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K: Reconstitution of the functional receptors for murine and human interleukin 5. J Exp Med 177:1523, 1993
8. Kitamura T, Sato N, Arai K, Miyajima A: Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165, 1991
9. Hayashida K, Kitamura K, Gorman DM, Arai K, Yokota T, Miyajima A: Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87:9655, 1990
10. Muto A, Watanabe S, Miyajima A, Yokota T, Arai K: The β subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the α subunit. J Exp Med 183:1911, 1996
11. Stomski FC, Sun Q, Bagley CJ, Woodcock J, Goodall G, Andrew RK, Berndt MC, Lopez AF: Human interleukin-3 (IL-3) induces disulfide-liked IL-3 receptor α- and β-chain heterodimerization, which is required for receptor activation but not high-affinity binding. Mol Cell Biol 16:3035, 1996
12. Bagley CJ, Woodcock JM, Stomski FC, Lopez AF: The structural and functional basis of cytokine receptor activation: Lessons from the common β subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors. Blood 89:1471, 1997
13. Takaki S, Kanazawa H, Shiiba M, Takatsu K: A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor α chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol 14:7404, 1994
14. Sato S, Katagiri T, Takaki S, Kikuchi Y, Hitoshi Y, Yonehara S, Tsukada S, Kitamura D, Watanabe T, Wine O, Takatsu K: IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 180:2101, 1994
15. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429, 1993
16. Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ: Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5:1329, 1990
17. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993
18. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253, 1994
19. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251, 1995
20. van der Bruggen T, Caldenhoven E, Kanters D, Coffer P, Raaijmakers JAM, Lammers JWJ, Koenderman L: Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat 1α. Blood 85:1442, 1995
21. Pazdrak K, Justement L, Alam R: Mechanism of inhibition of eosinophils activation by transforming growth factor-β. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 155:4454, 1995
22. Ogata N, Kikuchi Y, Kouro T, Takatsu K: The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human interleukin-5 receptor. Int Arch Allergy Immunol 114:24, 1997 (suppl)
23. Bates ME, Bertcs PJ, Busse WW: IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 156:711, 1996
24. Kouro T, Kikuchi Y, Kanazawa H, Hirokawa K, Harada N, Shiiba M, Wakao H, Takaki S, Takatsu K: Critical proline residues of the cytoplasmic domain of the IL-5 receptor a chain and its function in IL-5-mediated activation of JAK kinases and STATS. Int Immunol 8:237, 1996
25. Watanabe S, Itoh T, Arai K: JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptors in BA/F3 cells. J Biol Chem 271:12681, 1996
26. Dickason RR, Huston DP: Creation of a biologically active interleukin-5 monomer. Nature 379:652, 1996
27. Koike M, Iida A, Shoji E, Mikuni O, Furuya A, Anazawa H, Takaki S, Takatsu K, Hanai N: Monoclonal antibodies recognizing human interleukin 5 receptor alpha chain. Tissue Antigens 48:390, 1996 (abstr)
28. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Pia YF, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989
29. van den Hoff MJB, Moorman AFM, Lamers WH: Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res 20:2902, 1992
30. Lopez AF, Vadas MA, Woodcock JM, Milton SE, Lewis A, Elliott MJ, Gillis D, Ireland R, Olwell E, Park LS: Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 266:24741, 1991
31. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237, 1993
32. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbiert G, Pellegrini S, Ihle JN, Yancopoulos GD: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science 263:92, 1994
33. IL-3. Blood 89:4327, 1997
34. Cattaneo E, De Fraja C, Conti L, Renach B, Bolos L, Govoni S, Liboi E: Activation of JAK/STAT pathway leads to proliferation of ST14A central nervous system progenitor cells. J Biol Chem 271: 23374, 1996
35. Brizzi MF, Aronoca MG, Rosso A, Bagnara GP, Yarden Y, Pegoraro L: Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem 27:3562, 1996
36. Quelle FW, Sato N, Witthuhn BA, Inhom RC, Eder M, Miyajima A, Griffin JD, IhLe JN: JAK2 associates with the βc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335, 1994
37. Higuchi M, Asao H, Tanaka N, Oda K, Takeshita T, Nakamura M, van Snick J, Sugamura K: Dispensability of Jak 1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Eur J Immunol 26:1322, 1996
38. Oakes SA, Candotti F, Johnston JA, Chen YQ, Ryan JJ, Tayor N, Liu X, Hennighausen L, Notarangelo LD, Paul WE, Blaese RM, O'Shea JJ: Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605, 1996
39. Johanson K, Applebaum E, Doyle M, Hensley P, Zhao B, Abdel-Meguid SS, Young P, Cook R, Carr S, Matico R, Cusimano D, Dul E, Angelichio M, Brooks I, Winborne E, McDonnell P, Morton T, Bennett D, Sokoloski T, McNulty D, Rosenberg M, Chaiken I: Binding interactions of human interleukin 5 with its receptor a subunit. J Biol Chem 270:9459, 1995
40. Devos R, Guisez Y, Cornelius S, Verhee A, Van der Heyden J, Manneberg M, Lahm HW, Fiers W, Tavernier J, Plaetinck G: Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. J Biol Chem 268:6581, 1993
41. Li J, Cook R, Chaiken I: Mutants of single chain interleukin 5 show asymmetric recruitment of receptor α and βc subunits. J Biol Chem 271:31729, 1996
42. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R: The intercellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK microtubule-associated protein kinase pathway. J Exp Med 181:1827, 1995
43. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 183:1407, 1996